The economic impact of prematurity and bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, duri...
Gespeichert in:
Veröffentlicht in: | European journal of pediatrics 2017-12, Vol.176 (12), p.1587-1593 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1593 |
---|---|
container_issue | 12 |
container_start_page | 1587 |
container_title | European journal of pediatrics |
container_volume | 176 |
creator | Álvarez-Fuente, María Arruza, Luis Muro, Marta Zozaya, Carlos Avila, Alejandro López-Ortego, Paloma González-Armengod, Carmen Torrent, Alba Gavilán, Jose Luis del Cerro, María Jesús |
description | Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €.
Conclusion
: Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority.
What is known:
• Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth.
• BPD is an increasing disease due to the up-rise in the number of premature births.
What is new:
• The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data.
• Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden. |
doi_str_mv | 10.1007/s00431-017-3009-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1937756838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1937756838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</originalsourceid><addsrcrecordid>eNp1kLtKBDEUhoMoul4ewEYGbGyiJ5NsLqWINxBs1jpkc3FHZiZjMlPs25tlVxHBKsX5_v_kfAidE7gmAOImAzBKMBCBKYDCfA_NCKM1JiD4PpoBZYA5UeoIHef8ASWjiDxER7WUUhFVz9DtYuUrb2Mfu8ZWTTcYO1YxVEPynRmn1IzryvSuWqbY21UcpraLvUnryq3z0JrcmFN0EEyb_dnuPUFvD_eLuyf88vr4fHf7gi0V9YjDnPgADJSw86WzjlGnlPK1oU4w5ZxySoKVkgoWQuDW1mB4YEsenANbO3qCrra9Q4qfk8-j7ppsfdua3scpa6KoEHMuqSzo5R_0I06pL78rFCeCUUFZociWsinmnHzQQ2q6cpsmoDd-9davLn71xq_mJXOxa56WnXc_iW-hBai3QC6j_t2nX6v_bf0CJO2F2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1961743734</pqid></control><display><type>article</type><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</creator><creatorcontrib>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</creatorcontrib><description>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €.
Conclusion
: Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority.
What is known:
• Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth.
• BPD is an increasing disease due to the up-rise in the number of premature births.
What is new:
• The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data.
• Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s00431-017-3009-6</identifier><identifier>PMID: 28889192</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Babies ; Birth weight ; Bronchopulmonary Dysplasia - economics ; Bronchopulmonary Dysplasia - epidemiology ; Bronchopulmonary Dysplasia - therapy ; Child, Preschool ; Databases, Factual ; Dysplasia ; Female ; Follow-Up Studies ; Gestational age ; Health Care Costs - statistics & numerical data ; Humans ; Incidence ; Infant ; Infant, Newborn ; Infant, Premature ; Lung diseases ; Male ; Mechanical ventilation ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Neonates ; Original Article ; Oxygen ; Oxygen therapy ; Pediatrics ; Premature birth ; Public health ; Respiratory therapy ; Spain - epidemiology ; Ventilation</subject><ispartof>European journal of pediatrics, 2017-12, Vol.176 (12), p.1587-1593</ispartof><rights>Springer-Verlag GmbH Germany 2017</rights><rights>European Journal of Pediatrics is a copyright of Springer, (2017). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</citedby><cites>FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00431-017-3009-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00431-017-3009-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28889192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Álvarez-Fuente, María</creatorcontrib><creatorcontrib>Arruza, Luis</creatorcontrib><creatorcontrib>Muro, Marta</creatorcontrib><creatorcontrib>Zozaya, Carlos</creatorcontrib><creatorcontrib>Avila, Alejandro</creatorcontrib><creatorcontrib>López-Ortego, Paloma</creatorcontrib><creatorcontrib>González-Armengod, Carmen</creatorcontrib><creatorcontrib>Torrent, Alba</creatorcontrib><creatorcontrib>Gavilán, Jose Luis</creatorcontrib><creatorcontrib>del Cerro, María Jesús</creatorcontrib><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><addtitle>Eur J Pediatr</addtitle><description>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €.
Conclusion
: Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority.
What is known:
• Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth.
• BPD is an increasing disease due to the up-rise in the number of premature births.
What is new:
• The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data.
• Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</description><subject>Babies</subject><subject>Birth weight</subject><subject>Bronchopulmonary Dysplasia - economics</subject><subject>Bronchopulmonary Dysplasia - epidemiology</subject><subject>Bronchopulmonary Dysplasia - therapy</subject><subject>Child, Preschool</subject><subject>Databases, Factual</subject><subject>Dysplasia</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gestational age</subject><subject>Health Care Costs - statistics & numerical data</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Lung diseases</subject><subject>Male</subject><subject>Mechanical ventilation</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Neonates</subject><subject>Original Article</subject><subject>Oxygen</subject><subject>Oxygen therapy</subject><subject>Pediatrics</subject><subject>Premature birth</subject><subject>Public health</subject><subject>Respiratory therapy</subject><subject>Spain - epidemiology</subject><subject>Ventilation</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kLtKBDEUhoMoul4ewEYGbGyiJ5NsLqWINxBs1jpkc3FHZiZjMlPs25tlVxHBKsX5_v_kfAidE7gmAOImAzBKMBCBKYDCfA_NCKM1JiD4PpoBZYA5UeoIHef8ASWjiDxER7WUUhFVz9DtYuUrb2Mfu8ZWTTcYO1YxVEPynRmn1IzryvSuWqbY21UcpraLvUnryq3z0JrcmFN0EEyb_dnuPUFvD_eLuyf88vr4fHf7gi0V9YjDnPgADJSw86WzjlGnlPK1oU4w5ZxySoKVkgoWQuDW1mB4YEsenANbO3qCrra9Q4qfk8-j7ppsfdua3scpa6KoEHMuqSzo5R_0I06pL78rFCeCUUFZociWsinmnHzQQ2q6cpsmoDd-9davLn71xq_mJXOxa56WnXc_iW-hBai3QC6j_t2nX6v_bf0CJO2F2A</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Álvarez-Fuente, María</creator><creator>Arruza, Luis</creator><creator>Muro, Marta</creator><creator>Zozaya, Carlos</creator><creator>Avila, Alejandro</creator><creator>López-Ortego, Paloma</creator><creator>González-Armengod, Carmen</creator><creator>Torrent, Alba</creator><creator>Gavilán, Jose Luis</creator><creator>del Cerro, María Jesús</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>The economic impact of prematurity and bronchopulmonary dysplasia</title><author>Álvarez-Fuente, María ; Arruza, Luis ; Muro, Marta ; Zozaya, Carlos ; Avila, Alejandro ; López-Ortego, Paloma ; González-Armengod, Carmen ; Torrent, Alba ; Gavilán, Jose Luis ; del Cerro, María Jesús</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f51ef04097c5bdcd43d999e2a3d749dd9d980c88374fff6cc20a6f4b6fdd0c2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Babies</topic><topic>Birth weight</topic><topic>Bronchopulmonary Dysplasia - economics</topic><topic>Bronchopulmonary Dysplasia - epidemiology</topic><topic>Bronchopulmonary Dysplasia - therapy</topic><topic>Child, Preschool</topic><topic>Databases, Factual</topic><topic>Dysplasia</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gestational age</topic><topic>Health Care Costs - statistics & numerical data</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Lung diseases</topic><topic>Male</topic><topic>Mechanical ventilation</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Neonates</topic><topic>Original Article</topic><topic>Oxygen</topic><topic>Oxygen therapy</topic><topic>Pediatrics</topic><topic>Premature birth</topic><topic>Public health</topic><topic>Respiratory therapy</topic><topic>Spain - epidemiology</topic><topic>Ventilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez-Fuente, María</creatorcontrib><creatorcontrib>Arruza, Luis</creatorcontrib><creatorcontrib>Muro, Marta</creatorcontrib><creatorcontrib>Zozaya, Carlos</creatorcontrib><creatorcontrib>Avila, Alejandro</creatorcontrib><creatorcontrib>López-Ortego, Paloma</creatorcontrib><creatorcontrib>González-Armengod, Carmen</creatorcontrib><creatorcontrib>Torrent, Alba</creatorcontrib><creatorcontrib>Gavilán, Jose Luis</creatorcontrib><creatorcontrib>del Cerro, María Jesús</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez-Fuente, María</au><au>Arruza, Luis</au><au>Muro, Marta</au><au>Zozaya, Carlos</au><au>Avila, Alejandro</au><au>López-Ortego, Paloma</au><au>González-Armengod, Carmen</au><au>Torrent, Alba</au><au>Gavilán, Jose Luis</au><au>del Cerro, María Jesús</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The economic impact of prematurity and bronchopulmonary dysplasia</atitle><jtitle>European journal of pediatrics</jtitle><stitle>Eur J Pediatr</stitle><addtitle>Eur J Pediatr</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>176</volume><issue>12</issue><spage>1587</spage><epage>1593</epage><pages>1587-1593</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>Bronchopulmonary dysplasia (BPD) is one of the most serious chronic lung diseases in infancy and one of the most important sequels of premature birth (prevalence of 15–50%). Our objective was to estimate the cost of BPD of one preterm baby, with no other major prematurity-related complications, during the first 2 years of life in Spain. Data from the Spanish Ministry of Health regarding costs of diagnosis-related group of preterm birth, hospital admissions and visits, palivizumab administration, and oxygen therapy in the year 2013 were analyzed. In 2013, 2628 preterm babies were born with a weight under 1500 g; 50.9% were males. The need for respiratory support was 2.5% needed only oxygen therapy, 39.5% required conventional mechanical ventilation, and 14.9% required high-frequency ventilation. The incidence of BPD was of 34.9%. The cost of the first 2 years of life of a preterm baby with BPD and no other major prematurity-related complications ranged between 45,049.81 € and 118,760.43 €, in Spain, depending on birth weight and gestational age. If the baby required home oxygen therapy or developed pulmonary hypertension, this cost could add up to 181,742.43 €.
Conclusion
: Prematurity and BPD have an elevated cost, even for public health care systems. This cost will probably increase in the coming years if the incidence and survival of preterm babies keeps rising. The development of new therapies and preventive strategies to decrease the incidence of BPD and other morbidities associated with prematurity should be a priority.
What is known:
• Bronchopulmonary dysplasia (BPD) is a serious chronic lung disease related with premature birth.
• BPD is an increasing disease due to the up-rise in the number of premature births.
What is new:
• The economic cost of preterm birth and BPD has never before been estimated in Spain nor published with European data.
• Preterm babies with BPD and a good clinical outcome carry also an important economic and social burden.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>28889192</pmid><doi>10.1007/s00431-017-3009-6</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 2017-12, Vol.176 (12), p.1587-1593 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_1937756838 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Babies Birth weight Bronchopulmonary Dysplasia - economics Bronchopulmonary Dysplasia - epidemiology Bronchopulmonary Dysplasia - therapy Child, Preschool Databases, Factual Dysplasia Female Follow-Up Studies Gestational age Health Care Costs - statistics & numerical data Humans Incidence Infant Infant, Newborn Infant, Premature Lung diseases Male Mechanical ventilation Medicine Medicine & Public Health Monoclonal antibodies Neonates Original Article Oxygen Oxygen therapy Pediatrics Premature birth Public health Respiratory therapy Spain - epidemiology Ventilation |
title | The economic impact of prematurity and bronchopulmonary dysplasia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T19%3A03%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20economic%20impact%20of%20prematurity%20and%20bronchopulmonary%20dysplasia&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=%C3%81lvarez-Fuente,%20Mar%C3%ADa&rft.date=2017-12-01&rft.volume=176&rft.issue=12&rft.spage=1587&rft.epage=1593&rft.pages=1587-1593&rft.issn=0340-6199&rft.eissn=1432-1076&rft_id=info:doi/10.1007/s00431-017-3009-6&rft_dat=%3Cproquest_cross%3E1937756838%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1961743734&rft_id=info:pmid/28889192&rfr_iscdi=true |